AbbVie

Open: 154.05 Close: 154.56 Change: 0.51

Don't invest in AbbVie before reading this automated analysis produce by an AI.

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, HSBC, rating, downgrade, share, report, company, and the most common words in the summary are: abbvie, stock, inc, market, price, abbv, buy, . One of the sentences in the summary was: HSBC cut its holdings in shares of the company.. Other searches related to this …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

HSBC downgraded shares of AbbVie from a buy rating to a hold rating in a research report sent to investors on Monday morning. HSBC cut its holdings in shares of the company.

Today's News

HSBC downgraded shares of AbbVie from a buy rating to a hold rating in a research report sent to investors on Monday morning. HSBC cut its holdings in shares of the company. HSBC analyst Rajesh Kumar downgrades AbbVie from Buy to Hold, Lowers Price Target to $156. HSBC initiated coverage of Thermo Fisher Scientific (NYSE:TMO) and Teva Pharma (NYSE) with Buy ratings. AbbVie beat two rival bidders to acquire immunogen for $10b, sec filings show – endpoints news. Weve spotted 4 warning signs for Abbvie you should be aware. AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. A recently filed patent describes a method for treating active psoriatic arthritis in human patients. AbbVie stock is higher by 0.12% while the S&P 500 is lower by -0.05% as of 11:13 AM on Wednesday. The annual report, examining price increases it says are not backed by clinical data. Anima Biotech has entered into a major collaboration with US pharma major AbbVie (ABBVie: ABBV), which is potentially worth more than $580 million. AbbVie Inc. has partnered with Anima Biotech to co-develop mRNA-based candidates against three targets in oncology and immunology. The discovery of mRNA biology modulators will be based on Animas mRNA Lightning platform. Data Scientist II - R&D Data Solutions at AbbVie. Apply Now. This position is an opportunity for an early career candidate to join a team and work at the intersection of machine learning and artificial intelligence.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, HSBC, rating, downgrade, share, report, company, and the most common words in the summary are: abbvie, stock, inc, market, price, abbv, buy, . One of the sentences in the summary was: HSBC cut its holdings in shares of the company.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #inc #market #price #abbv #buy.